Nektar Therapeutics (NKTR)

Nektar Therapeutics Revenue

Nektar Therapeutics had revenue of $10.13M in the quarter ending June 30, 2026, a decrease of -9.34%. This brings the company's total for the last twelve months to $54.59M, down -27.15% year-over-year. In the year 2025, Nektar Therapeutics had annual revenue of $55.23M, down -43.89%. That makes Nektar Therapeutics the 27,354th largest company in the world by revenue and 3,720th in the United States.

• Revenue (ttm): $54.59M
• Revenue Growth: -27.15%
• P/S Ratio: 24.31
• Revenue / Employee: $866,492
• Employees: 63
• Market Cap: 1.33B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Rest of World 97.05M 98.6%
• United States 1.38M 1.4%

Fiscal year ended Dec 31, 2024 See the full Nektar Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	55.23M	-43.20M	-43.89%
Dec 31, 2024	98.43M	8.31M	9.22%
Dec 31, 2023	90.12M	-1.93M	-2.10%
Dec 31, 2022	92.06M	-9.85M	-9.67%
Dec 31, 2021	101.91M	-51.01M	-33.36%
Dec 31, 2020	152.92M	38.30M	33.41%
Dec 31, 2019	114.62M	-1.08B	-90.40%
Dec 31, 2018	1.19B	885.61M	287.81%
Dec 31, 2017	307.71M	142.28M	86.00%
Dec 31, 2016	165.44M	-65.35M	-28.32%
Dec 31, 2015	230.78M	30.08M	14.99%
Dec 31, 2014	200.71M	51.79M	34.77%
Dec 31, 2013	148.92M	67.73M	83.42%
Dec 31, 2012	81.19M	9.71M	13.59%
Dec 31, 2011	71.48M	-87.56M	-55.06%
Dec 31, 2010	159.04M	87.11M	121.10%
Dec 31, 2009	71.93M	-18.25M	-20.24%
Dec 31, 2008	90.19M	-182.84M	-66.97%
Dec 31, 2007	273.03M	55.31M	25.40%
Dec 31, 2006	217.72M	91.44M	72.41%
Dec 31, 2005	126.28M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error